Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.24 USD 2.48%
Market Cap: 39.6m USD
Have any thoughts about
Co-Diagnostics Inc?
Write Note

Co-Diagnostics Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Co-Diagnostics Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Co-Diagnostics Inc
NASDAQ:CODX
Cash & Cash Equivalents
$13.9m
CAGR 3-Years
-42%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash & Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash & Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash & Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash & Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash & Cash Equivalents
$2.4B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
17%

See Also

What is Co-Diagnostics Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
13.9m USD

Based on the financial report for Jun 30, 2024, Co-Diagnostics Inc's Cash & Cash Equivalents amounts to 13.9m USD.

What is Co-Diagnostics Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
29%

Over the last year, the Cash & Cash Equivalents growth was 0%. The average annual Cash & Cash Equivalents growth rates for Co-Diagnostics Inc have been -42% over the past three years , 29% over the past five years .

Back to Top